Testing effectiveness (Phase 2)Study completedNCT00685399What this trial is testingSafety and Efficacy of AIN457 in Noninfectious UveitisWho this might be right forNon-infectious Uveitis Novartis Pharmaceuticals 76
Post-approval studies (Phase 4)UnknownNCT01306955What this trial is testingThe Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's DiseaseWho this might be right forBehcet's Disease Tehran University of Medical Sciences 34
Not applicableStudy completedNCT00331331What this trial is testingThe Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory DiseaseWho this might be right forUveitisVasculitisOcular Inflammatory Disease National Eye Institute (NEI) 147
Not applicableLooking for participantsNCT07065747What this trial is testingQuantification & Classification of Inflammatory Cells in Uveitis Using OCTWho this might be right forAnterior Uveitis (AU)Birdshot ChorioretinitisBehcet Disease+5 more Oregon Health and Science University 125
Post-approval studies (Phase 4)UnknownNCT03066869What this trial is testingEfficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal VasculitisWho this might be right forUveitis, PosteriorVasculitis Retinal Ocular Immunology and Uveitis Foundation 40
Not applicableUnknownNCT00931957What this trial is testingEtanercept: Single Blind Control Study in Ocular Manifestations of Behcet's DiseaseWho this might be right forBehcet SyndromeUveal Disease Tehran University of Medical Sciences 80
Not applicableStudy completedNCT06769412What this trial is testingA Real-World Evidence Study for the Incidence of Retinal Vasculitis (RV) Among Adult Patients Receiving Aflibercept 2 mg in the United States (US)Who this might be right forRetinal Vasculitis Regeneron Pharmaceuticals 550,000
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Not applicableStudy completedNCT00006188What this trial is testingEvaluation and Treatment of Patients With Inflammatory Eye DiseasesWho this might be right forChoroiditisIridocyclitisIritis+1 more National Eye Institute (NEI) 300
Not applicableStudy completedNCT00050492What this trial is testingBiological Markers in Retinal VasculitisWho this might be right forRetinal Vasculitis National Eye Institute (NEI) 200
Not applicableNot Yet RecruitingNCT07206238What this trial is testingOrbital Vascular Inflammation in Ischemic Optic Neuropathy and Giant Cell ArteritisWho this might be right forGiant Cell Arteritis (GCA)Ischemic Optic NeuropathyNAION - Non-Arteritic Ischemic Optic Neuropathy Rigshospitalet, Denmark 122
Not applicableNot Yet RecruitingNCT06343961What this trial is testingIntraoperative Application of Fluorescein Sodium Angiography in Vascular RetinopathyWho this might be right forVascular Retinopathy of Left Eye (Disorder)Vascular Retinopathy of Right Eye (Disorder)Diabetic Retinopathy+3 more Jie Zhong 80
Not applicableStudy completedNCT01998464What this trial is testingOptical Coherence Tomography (OCT) in Retinal VasculitisWho this might be right forRetinal Vasculitis Oregon Health and Science University 12
Large-scale testing (Phase 3)Study completedNCT00167583What this trial is testingInterferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)Who this might be right forBehcet's DiseasePanuveitisPosterior Uveitis+1 more University Hospital Tuebingen 37
Not applicableUnknownNCT04101604What this trial is testingBiomarkers of Common Eye DiseasesWho this might be right forUveitisDiabetic RetinopathyAge-related Macular Degeneration+3 more Sun Yat-sen University 220
Post-approval studies (Phase 4)Study completedNCT06613919What this trial is testingSix-months Versus Nine-months ATT for Ocular TBWho this might be right forTuberculosis (TB)UveitisRetinal Vasculitis+1 more L.V. Prasad Eye Institute 58
Not applicableStudy completedNCT05657158What this trial is testingAnalysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular OcclusionWho this might be right forIntraocular InflammationRetinal Vascular Occlusion Novartis Pharmaceuticals 198
Not applicableLooking for participantsNCT05635266What this trial is testingTissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research InitiativesWho this might be right forAge-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more Sanguine Biosciences 20,000
Not applicableLooking for participantsNCT06500728What this trial is testingVisual Involvement in Giant Cell ArteritisWho this might be right forGiant Cell ArteritisVisual ImpairmentCentral Retinal Artery Occlusion+6 more ASST Fatebenefratelli Sacco 762
Testing effectiveness (Phase 2)Study completedNCT00664599What this trial is testingRituximab for the Treatment of Severe Ocular Manifestations of Behcet's DiseaseWho this might be right forBehcet's Syndrome Tehran University of Medical Sciences 20